APA (7th ed.) Citation

S, W., AT, K., RT, L., IM, K., D, L., SY, T., . . . AG, S. (2025). Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition. The Journal of clinical investigation, 135(22), . https://doi.org/10.1172/JCI189900

Chicago Style (17th ed.) Citation

S, Wilkinson, et al. "Localized High-risk Prostate Cancer Harbors an Androgen Receptor Activity-low Subpopulation Susceptible to HER2 Inhibition." The Journal of Clinical Investigation 135, no. 22 (2025). https://doi.org/10.1172/JCI189900.

MLA (9th ed.) Citation

S, Wilkinson, et al. "Localized High-risk Prostate Cancer Harbors an Androgen Receptor Activity-low Subpopulation Susceptible to HER2 Inhibition." The Journal of Clinical Investigation, vol. 135, no. 22, 2025, https://doi.org/10.1172/JCI189900.